Hypertension Research Today is a free monthly online journal that collates and summarizes the latest research about Hypertension, including details on symptoms, diagnosis, diet, treatment, causes.

Gamma-glutamyltransferase: an effect modifier in the association between age and hypertension in a 4-year follow-up study.

Lee DH, Ha MH, Kim KY, Jin DG, Jacobs DR

Department of Preventive Medicine and Health Promotion Research Center, School of Medicine, Kyungpook University, Daegu, Korea. lee_dh@knu.ac.kr

We performed a prospective study to assess whether the relationship of age with hypertension was stronger in men with high normal serum gamma glutamyltransferase (GGT) than in those with lower GGT levels. The study population included 8170 healthy male workers in a steel manufacturing company who had undergone health examinations in both 1994 and 1998. The higher the baseline GGT level, the effect of age on the development of hypertension was stronger. The incidence of hypertension among those aged 25-34, 35-44 and 45-50 years was 0.9, 2.2, 3.8% in those with GGT<20 U/l; 1.0, 4.1, 12.5% in those with GGT between 20 and 39 U/l; and 1.9, 6.3, 17.2% in those with GGT> or =40 U/l, respectively. All relationships persisted after adjusting for baseline values of body mass index, alcohol intake, smoking, exercise, family history of hypertension, systolic and diastolic blood pressure, and changes of body mass index during 4 years (P for interaction=0.03). Our data supported the hypothesis that the effect of age on the development of hypertension differed by baseline GGT level, although the underlying mechanism for this interaction is unclear.

Published 21 October 2004 in J Hum Hypertens, 18(11): 803-7.
Full-text of this article is available online (may require subscription).

© 2004-2008 Hypertension Research Today. All Rights Reserved.